| 1 |
Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression
Denis Joseph Paul David, Benjamin Adam Samuels, Quentin Rainer et al. · Neuron
Open access |
May 2009 |
1,263 |
| 2 |
Transcriptomic analysis of purified human cortical microglia reveals age-associated changes
Thais Fernanda de Almeida Galatro, Inge R. Holtman, Antônio Marcondes Lerário et al. · Nature Neuroscience
Open access |
3 Jul 2017 |
818 |
| 3 |
Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis
Inge R. Holtman, Divya D. A. Raj, Jeremy A. Miller et al. · Acta Neuropathologica Communications
Open access |
21 May 2015 |
694 |
| 4 |
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
Benny Bang‐Andersen, Thomas M. Ruhland, Morten Jørgensen et al. · Journal of Medicinal Chemistry
Open access |
12 Apr 2011 |
604 |
| 5 |
Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
Jeffrey L. Cummings, Gary Tong, Clive G. Ballard · Journal of Alzheimer s Disease
Open access |
22 Jan 2019 |
594 |
| 6 |
Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Connie Sánchez, Karen E. Asin, Francesc Artigas · Pharmacology & Therapeutics
Open access |
9 Jul 2014 |
545 |
| 7 |
Current state of Alzheimer’s fluid biomarkers
José Luís Molinuevo, Scott Ayton, Richard Batrla et al. · Acta Neuropathologica
Open access |
28 Nov 2018 |
533 |
| 8 |
The Economic Burden of Schizophrenia in the United States in 2013
Martin Cloutier, Myrlene Sanon Aigbogun, Annie Guérin et al. · The Journal of Clinical Psychiatry
|
25 Apr 2016 |
494 |
| 9 |
Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer’s Disease Model
Mario Merlini, Victoria A. Rafalski, Pamela E. Rios Coronado et al. · Neuron
Open access |
5 Feb 2019 |
457 |
| 10 |
NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
Adam K. Walker, David P. Budac, Stephanie Bisulco et al. · Neuropsychopharmacology
Open access |
19 Mar 2013 |
444 |
| 11 |
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
Messoud Ashina, Joel R. Saper, Roger K. Cady et al. · Cephalalgia
Open access |
19 Feb 2020 |
405 |
| 12 |
Efficacy and safety of eptinezumab in patients with chronic migraine
Richard B. Lipton, Peter James Goadsby, Jeff Smith et al. · Neurology
Open access |
24 Mar 2020 |
404 |
| 13 |
Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor
Masaaki Iwata, Kristie T. Ota, Xiaoyuan Li et al. · Biological Psychiatry
|
14 Dec 2015 |
393 |
| 14 |
Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator
Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa et al. · Journal of Pharmacology and Experimental Therapeutics
|
20 Jun 2014 |
369 |
| 15 |
Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats
Arne Mørk, Liliana P. Montezinho, Silke Miller et al. · Pharmacology Biochemistry and Behavior
Open access |
Feb 2013 |
296 |
| 16 |
Prevalence of post-traumatic stress disorder in the United States: a systematic literature review
Jeffrey R Schein, Christy R. Houle, Annette Urganus et al. · Current Medical Research and Opinion
ReviewOpen access |
9 Sep 2021 |
283 |
| 17 |
A comparative review of escitalopram, paroxetine, and sertraline
Connie Sánchez, Elin Heldbo Reines, Stuart Montgomery · International Clinical Psychopharmacology
Open access |
14 Jan 2014 |
277 |
| 18 |
The role of the innate immune system in psychiatric disorders
KENNETH ARTHUR JONES, Christian Thomsen · Molecular and Cellular Neuroscience
|
17 Oct 2012 |
275 |
| 19 |
The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective
Lori L. Davis, Jeff R. Schein, Martin Cloutier et al. · The Journal of Clinical Psychiatry
Open access |
21 Apr 2022 |
260 |
| 20 |
The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia
Toni D. Wolinsky, Chad J. Swanson, Kelli E. Smith et al. · Genes Brain & Behavior
Open access |
15 Nov 2006 |
247 |
| 21 |
Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease
Zhuoran Yin, Divya D. A. Raj, Nasrin Saiepour et al. · Neurobiology of Aging
Open access |
27 Mar 2017 |
244 |
| 22 |
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Elena Dale, Benny Bang‐Andersen, Connie Sánchez · Biochemical Pharmacology
Open access |
5 Apr 2015 |
236 |
| 23 |
The economic burden of bipolar I disorder in the United States in 2015
Martin Cloutier, Mallik Greene, Annie Guérin et al. · Journal of Affective Disorders
Open access |
14 Sep 2017 |
222 |
| 24 |
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
Jae Kyu Ryu et al. · Nature Immunology
Open access |
11 Oct 2018 |
219 |
| 25 |
Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat
Chad J. Swanson, Kenneth W. Perry, Susanne Koch-Krueger et al. · Neuropharmacology
|
20 Jan 2006 |
218 |
| 26 |
Critical data‐based re‐evaluation of minocycline as a putative specific microglia inhibitor
Thomas Möller, Frédérique Bard, Anindya Bhattacharya et al. · Glia
|
Jun 2016 |
206 |
| 27 |
Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder
Mallik Greene, Tingjian Yan, Eunice Y Chang et al. · Journal of Medical Economics
Open access |
12 Sep 2017 |
202 |
| 28 |
Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease
Paul D. Wes, Inge R. Holtman, Erik Boddeke et al. · Glia
Open access |
4 Jun 2015 |
192 |
| 29 |
Targeting microglia for the treatment of Alzheimer's Disease
Paul D. Wes, Faten A. Sayed, Frédérique Bard et al. · Glia
|
21 Apr 2016 |
187 |
| 30 |
Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal 3 ) antagonists SNAP 37889 and SNAP 398299
Chad J. Swanson, Thomas P. Blackburn, Xuexiang Zhang et al. · Proceedings of the National Academy of Sciences
Open access |
15 Nov 2005 |
180 |
| 31 |
Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia
Bruce J. Kinon, Brian A. Millen, Lu Zhang et al. · Biological Psychiatry
|
29 Mar 2015 |
169 |
| 32 |
Epilepsy-related clinical characteristics and mortality
Olli Nevalainen, Hanna Ansakorpi, Mikko Simola et al. · Neurology
|
23 Oct 2014 |
166 |
| 33 |
The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review
Vladimir Maletic, Anna Eramo, Keva Gwin et al. · Frontiers in Psychiatry
ReviewOpen access |
16 Mar 2017 |
165 |
| 34 |
Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction
Alan Lars Pehrson, Connie Sánchez · CNS Spectrums
Open access |
Aug 2013 |
162 |
| 35 |
Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia
Dieter Naber, Karina Hansen, Carlos Forray et al. · Schizophrenia Research
Open access |
29 Jul 2015 |
159 |
| 36 |
Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters—A rat microdialysis and electrophysiology study
Alan Lars Pehrson, Thomas I.F.H. Cremers, Cécile Betry et al. · European Neuropsychopharmacology
|
23 May 2012 |
156 |
| 37 |
Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study
W. Wolfgang Fleischhacker, Raymond Sanchez, Pamela P. Perry et al. · The British Journal of Psychiatry
Open access |
13 Jun 2014 |
153 |
| 38 |
ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth
Jarrett R. Remsberg, Radu M. Suciu, Noemi A. Zambetti et al. · Nature Chemical Biology
Open access |
29 Apr 2021 |
151 |
| 39 |
Pregabalin is a potent and selective ligand for α2δ-1 and α2δ-2 calcium channel subunits
Zheng Li, Charles P. Taylor, Mark L. Weber et al. · European Journal of Pharmacology
|
5 Jun 2011 |
151 |
| 40 |
Droxidopa for the S hort‐ T erm T reatment of S ymptomatic N eurogenic O rthostatic H ypotension in P arkinson's D isease (n OH 306 B )
Robert A. Hauser, Stuart Isaacson, Jerome P. Lisk et al. · Movement Disorders
Open access |
9 Dec 2014 |
150 |
| 41 |
Silanediol Protease Inhibitors: From Conception to Validation
Scott McN. Sieburth, Chien‐An Chen · European Journal of Organic Chemistry
|
25 Oct 2005 |
148 |
| 42 |
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable
David S. Knopman et al. · Alzheimer s & Dementia
Open access |
Apr 2018 |
147 |
| 43 |
Randomized Withdrawal Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension Responsive to Droxidopa
Italo Biaggioni, Roy L. Freeman, Christopher J. Mathias et al. · Hypertension
Open access |
28 Oct 2014 |
147 |
| 44 |
Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants
Alan Lars Pehrson, Connie Sánchez · Drug Design Development and Therapy
Open access |
2015 |
145 |
| 45 |
HPA axis and sleep: Identifying subtypes of major depression
Irina A. Antonijevic, Irina A. Antonijevic · Stress
Open access |
2008 |
137 |
| 46 |
κ-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats
Kathryn A. Nealey, Alexander C.W. Smith, Seth M. Davis et al. · Neuropharmacology
Open access |
20 Feb 2011 |
135 |
| 47 |
Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: A potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism
Kristian Gaarn du Jardin, Jesper Bornø Jensen, Connie Sánchez et al. · European Neuropsychopharmacology
Open access |
2 Aug 2013 |
132 |
| 48 |
A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia
AnnCatherine M. Downing, Bruce J. Kinon, Brian A. Millen et al. · BMC Psychiatry
Open access |
Dec 2014 |
130 |
| 49 |
Decrease in parvalbumin‐expressing neurons in the hippocampus and increased phencyclidine‐induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia
Silke Penschuck, Peter Flagstad, Michael Didriksen et al. · European Journal of Neuroscience
Open access |
20 Dec 2005 |
129 |
| 50 |
Aligning strategies for using EEG as a surrogate biomarker: A review of preclinical and clinical research
Steven C. Leiser, John Dunlop, Mark R. Bowlby et al. · Biochemical Pharmacology
|
11 Oct 2010 |
123 |